GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Gilead Sciences, Inc. (GILD) [hlAlert]

Rating:
Buy GILD
up 414.23 %

Gilead Sciences, Inc. (GILD) rated Buy with price target $67 by UBS

Posted on: Friday,  May 17, 2013  10:25 AM ET by UBS

UBS rated Buy Gilead Sciences, Inc. (NASDAQ: GILD) on 05/17/2013. Previously UBS rated Buy Gilead Sciences, Inc. (NASDAQ: GILD) on 10/19/2007.,
when the stock price was $21.00. Since then, Gilead Sciences, Inc. has gained 414.24% as of 10/28/2015's recent price of $107.99.
If you would have followed the previous UBS's recommendation on GILD, you would have gained 414.23% of your investment in 2931 days.

Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company that discovers, develops, and commercializes therapeutics in areas of unmet medical need. The Company has United States and international commercial sales operations, with marketing subsidiaries in Australia, Austria, Canada, France, Germany, Greece, Ireland, Italy, New Zealand, Portugal, Spain, Switzerland, Turkey, United Kingdom, and United States. Its commercial team promotes Truvada, Viread, Emtriva, Hepsera, AmBisome, Letairis, and Flolan through direct field contact with physicians, hospitals, clinics, and other healthcare providers. Gilead?s corporate partner, Astellas Pharma, Inc. (Astellas), promotes and sells AmBisome in the United States, Canada, Europe, Australia, and New Zealand. In May 2008, the Company acquired Navitas Assets, LLC?s. In April 2009, the Company announced the completion of its acquisition of CV Therapeutics, Inc.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/17/2013 10:25 AM Buy
None
55.85 67.00
as of 12/13/2013
1 Week down  -3.50 %
1 Month up  4.23 %
3 Months up  12.38 %
1 YTD up  94.41 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/5/2013 12:25 PM Buy
None
40.47 48.00
1/30/2013 10:25 AM Buy
None
39.98 47.00
12/18/2012 10:25 AM Buy
None
37.84 43.50
8/30/2012 11:25 AM Buy
None
28.83 32.50
2/6/2012 12:25 PM Buy
None
27.78 30.50
11/22/2011 12:25 PM Buy
None
19.32 24.50
9/16/2011 12:25 PM Buy
None
20.20 23.00
3/23/2011 10:25 AM Buy
None
20.46 23.50
11/16/2010 11:25 AM Buy
None
18.99 22.00
1/28/2009 2:25 PM Buy
None
25.27 30.00
4/10/2008 9:25 AM Buy
None
25.77 29.50
3/3/2008 10:25 AM Buy
None
24.24 29.00
1/31/2008 9:25 AM Buy
None
22.43 28.50
1/11/2008 8:25 AM Buy
None
24.20 30.50
10/19/2007 9:25 AM Buy
None
21.00 25.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy